15.04.2025 • News

Cellasto Invests €60 million to Establish Second Plant in China

Cellasto, the world leader in Noise, Vibration and Harshness (NVH) components, is investing roughly €60 million to establish a second plant in Shanghai, China.

© BASF
© BASF

This production expansion aims to capitalize on China’s booming electric vehicle market. The new facility will feature advanced mold lines, resulting in a capacity increase of nearly 70%, with operations expected to start in 2027. A commencement ceremony was held on April 14 to celebrate this expansion.

“Cellasto has always delivered exceptional value to automotive manufacturers with the same passion for quality and efficiency. I am confident that this devotion will ensure a continued success with our customers in China in this vital automotive market,” commented Martin Jung, President of the Performance Materials Division, BASF.

“BASF has made substantial investments in China since entering the Chinese market 140 years ago.  Today’s expansion is another strong testament to BASF’s commitment to staying close to the local market and our customers. As the leading chemical supplier to the automotive industry, BASF strives to accelerate business growth in the automotive sector in China, by leveraging our local production network, strong innovation capabilities and deep market insights,” added Jeffrey Lou, President and Chairman Greater China, BASF.

“Four years ago, we celebrated Cellasto's 60th anniversary and the 10th anniversary of our Shanghai plant. This year, with the addition of a second plant, we are achieving another significant milestone. With our state-of-the-art facilities, we are eager to seize the opportunities presented by this dynamic market,” concludes Bjoern Kophstahl, Vice President of Cellasto.

Company

Logo:

BASF SE

Carl-Bosch-Straße 38
67056 Ludwigshafen
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read